Testosterone vaginal - Catalent
Alternative Names: Testosterone PHVT; Testosterone progressive hydration vaginal tabletLatest Information Update: 13 Nov 2021
At a glance
- Originator Columbia Laboratories
- Developer Catalent
- Class Anabolic steroids; Androstenols; Erectile dysfunction therapies; Hormonal replacements; Small molecules; Testosterone congeners
- Mechanism of Action Testosterone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Menopausal syndrome; Uterine leiomyoma
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for phase-I development in Menopausal-syndrome in USA (Vaginal, Tablet)
- 16 Jul 2016 No recent reports of development identified for phase-I development in Uterine-leiomyoma in USA (Vaginal, Tablet)
- 01 Apr 2015 Columbia Laboratories is now called Juniper Pharmaceuticals